Home/Filings/4/0000899243-22-018778
4//SEC Filing

CROCKER GARY L 4

Accession 0000899243-22-018778

CIK 0001274792other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:05 PM ET

Size

7.7 KB

Accession

0000899243-22-018778

Insider Transaction Report

Form 4
Period: 2022-05-17
Transactions
  • Purchase

    Common Stock

    2022-05-17$5.10/sh+225$1,147118,037 total(indirect: See footnote)
  • Purchase

    Common Stock

    2022-05-18$5.08/sh+5,000$25,407123,037 total(indirect: See footnote)
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.94 to $5.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother
IncorporatedUT

Related Parties

1
  • filerCIK 0001094201

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:05 PM ET
Size
7.7 KB